Shinichi Koizumi
Director/Board Member at TSUBOTA LABORATORY INCORPORATED
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Kazuo Tsubota | M | 69 | 12 years | |
| Shintaro Yamada | M | 51 | 12 years | |
| Akihiro Furuta | M | 64 |
AskAt, Inc.
 AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | - |
| Shinichiro Kondo | M | 55 | 9 years | |
| Takanari Shimizu | M | - | - | |
| Andrew M. Saidel | M | - |
AskAt, Inc.
AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | - |
| Masami Nakane | M | - |
AskAt, Inc.
AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | - |
| Hironari Hatsuzawa | M | - |
AskAt, Inc.
AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | - |
| Daisuke Nishii | M | - |
AskAt, Inc.
AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | - |
| Tatsuya Asai | M | - |
AskAt, Inc.
AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Pailin Chuchottaworn | M | 67 |
Tokyo Institute of Technology
| 4 years |
| Tadashi Miyashita | M | 63 |
Tokyo Institute of Technology
| 6 years |
| Koichiro Ikudome | M | - |
Tokyo Institute of Technology
| 1 years |
| Bin Cheng | M | 61 |
Tokyo Institute of Technology
| 4 years |
| Yong Xiang Wang | M | 71 |
Tokyo Institute of Technology
| 1 years |
| Noriya Yokota | M | 63 |
Tokyo Institute of Technology
| 4 years |
| Tomoaki Kobayakawa | M | 61 |
Tokyo Institute of Technology
| 4 years |
| Hiroyuki Kumehara | M | 80 |
Tokyo Institute of Technology
| 3 years |
| Hiroshi Tanie | M | - |
Tokyo Institute of Technology
| 4 years |
| Hironori Tateiri | M | - |
Tokyo Institute of Technology
| 4 years |
| Junichi Rekimoto | M | - |
Tokyo Institute of Technology
| 1 years |
| Yosuke Arimoto | M | 61 |
Tokyo Institute of Technology
| 4 years |
| Yasuo Naruke | M | 69 |
Tokyo Institute of Technology
| 3 years |
| Satoshi Ogiso | M | 63 |
Tokyo Institute of Technology
| 4 years |
| Jim Wang | M | 62 |
Tokyo Institute of Technology
| 3 years |
| Setsu Mimura | M | 60 |
Tokyo Institute of Technology
| 4 years |
| CK Choun | M | - |
Tokyo Institute of Technology
| 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Japan | 27 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Shinichi Koizumi
- Personal Network